Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 11-Apr-24 4:05 PM View:  | Finn Jonathan Director | Atossa Therapeutics, Inc. (ATOS) | 10-Apr-24 | Private Purchase | 25,000 | $1.77 | $44,250.00 | 100% 0 to 25.0K | |
| 17-Nov-23 4:01 PM View: | Weaver Gregory L Former EVP, CFO, & Director Director | Atossa Therapeutics, Inc. (ATOS) | 15-Nov-23 | Sale | 50,000 | $0.65 | $32,500.00 | (100%) 50.05K to 55 | |
| 16-Nov-17 6:03 AM View: | Guse Kyle CFO, Gen Counsel and Secretary | Atossa Therapeutics, Inc. (ATOS) | 15-Nov-17 | Market Purchase | 10,000 | $0.34 | $3,369.30 | 100% 0 to 10.0K | (63%) |
| 18-Apr-17 5:10 PM View: | Remmel H. Lawrence Director | Atossa Therapeutics, Inc. (ATOS) | 17-Apr-17 | Market Purchase | 2,500 | $0.63 | $1,580.00 | 399% 0.63K to 3.13K | (80%) |
| 04-Apr-16 2:02 PM View: | Remmel H. Lawrence Director | Atossa Therapeutics, Inc. (ATOS) | 01-Apr-16 | Market Purchase | 1,500 | $0.33 | $495.00 | 16% 9.4K to 10.9K | (97%) |
| 10-Mar-16 2:05 PM View: | Quay Steven C President & CEO Director 10% Owner | Atossa Therapeutics, Inc. (ATOS) | 09-Mar-16 | Market Purchase | 15,000 | $0.37 | $5,550.00 | < 1% 4.81M to 4.83M | (98%) |
| 10-Mar-16 2:08 PM View: | Chen Shu-Chih Director 10% Owner | Atossa Therapeutics, Inc. (ATOS) | 09-Mar-16 | Market Purchase Duplicate | 15,000 | $0.37 | $5,550.00 | < 1% 4.33M to 4.35M | (98%) |
| 17-Feb-16 3:04 PM View: | Quay Steven C President & CEO Director 10% Owner | Atossa Therapeutics, Inc. (ATOS) | 16-Feb-16 | Market Purchase Duplicate | 15,000 | $0.53 | $7,950.00 | < 1% 4.8M to 4.81M | (98%) |
| 17-Feb-16 3:03 PM View: | Chen Shu-Chih Director 10% Owner | Atossa Therapeutics, Inc. (ATOS) | 16-Feb-16 | Market Purchase | 15,000 | $0.53 | $7,950.00 | < 1% 4.32M to 4.33M | (98%) |
| 21-Jan-16 1:55 PM View: | Chen Shu-Chih Director 10% Owner | Atossa Therapeutics, Inc. (ATOS) | 19-Jan-16 | Market Purchase Duplicate | 50,000 | $0.20 | $10,000.00 | 1% 4.27M to 4.32M | (96%) |
| 21-Jan-16 1:54 PM View: | Quay Steven C President & CEO Director 10% Owner | Atossa Therapeutics, Inc. (ATOS) | 19-Jan-16 | Market Purchase | 50,000 | $0.20 | $10,000.00 | 1% 4.75M to 4.8M | (96%) |
| 15-Jun-15 3:28 PM View: | Remmel H. Lawrence Director | Atossa Therapeutics, Inc. (ATOS) | 12-Jun-15 | Market Purchase | 5,400 | $1.30 | $7,020.00 | 135% 4.0K to 9.4K | (99%) |
| 08-May-14 9:37 PM View: | Weaver Gregory L Director | Atossa Therapeutics, Inc. (ATOS) | 06-May-14 | Disposition | 24,510 | -- | -- | (100%) 24.51K to 0 | |
| 08-May-14 9:34 PM View: | Steinhart Richard I Director | Atossa Therapeutics, Inc. (ATOS) | 06-May-14 | Disposition | 22,728 | -- | -- | (100%) 22.73K to 0 | |
| 04-Mar-14 6:24 PM View: | Steinhart Richard I Director | Atossa Therapeutics, Inc. (ATOS) | 01-Mar-14 | Grant | 22,728 | -- | -- | 100% 0 to 22.73K | |
| 22-Nov-13 2:37 PM View: | Weaver Gregory L Director | Atossa Therapeutics, Inc. (ATOS) | 21-Nov-13 | Market Purchase | 10,000 | $2.58 | $25,785.00 | 41% 24.51K to 34.51K | (100%) |
| 15-Oct-13 9:00 PM View: | Weaver Gregory L Director | Atossa Therapeutics, Inc. (ATOS) | 10-Oct-13 | Grant | 24,510 | -- | -- | 100% 0 to 24.51K | |
| 03-Oct-13 6:22 PM View: | Chen Shu-Chih Chief Scientific Officer Director 10% Owner | Atossa Therapeutics, Inc. (ATOS) | 01-Oct-13 | Market Sale (Planned) | 7,265 | $5.66 | $41,105.40 | (< 1%) 4.28M to 4.27M | 100% |
| 03-Oct-13 6:59 PM View: | Quay Steven C Chief Executive Officer Director 10% Owner | Atossa Therapeutics, Inc. (ATOS) | 01-Oct-13 | Market Sale (Planned) Duplicate | 7,265 | $5.66 | $41,105.40 | (< 1%) 4.86M to 4.85M | 100% |
| 14-Feb-14 4:21 PM View: | Chen Shu-Chih Chief Scientific Officer Director 10% Owner | Atossa Therapeutics, Inc. (ATOS) | 18-Jul-13 | Gift Duplicate | 105,000 | -- | -- | (2%) 4.85M to 4.75M | |
| 14-Feb-14 4:23 PM View: | Quay Steven C Chief Executive Officer Director 10% Owner | Atossa Therapeutics, Inc. (ATOS) | 18-Jul-13 | Gift | 105,000 | -- | -- | (2%) 4.85M to 4.75M | |
| 14-Feb-14 4:23 PM View: | Quay Steven C Chief Executive Officer Director 10% Owner | Atossa Therapeutics, Inc. (ATOS) | 28-May-13 | Gift | 1,000 | -- | -- | (< 1%) 4.85M to 4.85M | |
| 14-Feb-14 4:21 PM View: | Chen Shu-Chih Chief Scientific Officer Director 10% Owner | Atossa Therapeutics, Inc. (ATOS) | 28-May-13 | Gift Duplicate | 1,000 | -- | -- | (< 1%) 4.85M to 4.85M | |
| 27-Jun-13 4:58 PM View: | Cross Alexander D Director | Atossa Therapeutics, Inc. (ATOS) | 15-May-13 | Market Purchase | 500 | $5.49 | $2,744.95 | < 1% 88.37K to 88.87K | (100%) |
| 09-Jan-13 5:45 PM View: | Remmel H. Lawrence Director | Atossa Therapeutics, Inc. (ATOS) | 08-Jan-13 | Purchase | 2,000 | $4.05 | $8,100.00 | 100% 2.0K to 4.0K | |
| 09-Jan-13 5:45 PM View: | Remmel H. Lawrence Director | Atossa Therapeutics, Inc. (ATOS) | 08-Jan-13 | Purchase | 2,000 | $4.18 | $8,360.00 | 100% 0 to 2.0K |
